Eli Lilly and Company
The Executive Director, Cutaneous Biology Innovation & Strategic Partnerships guides the strategy for the Immunology therapeutic area, including dermatology and epithelial barrier research. They will provide scientific leadership for external and academic collaborations, identify partnership opportunities, and new company creation initiatives, focusing on epithelial and hair follicle biology. This role serves as the scientific interface between internal immunology portfolio strategy and external innovation, aligning with therapeutic area goals and executing transformative partnerships for dermatologic diseases.